: an anticoagulant drug C19H18ClN3O5S that inhibits the activity of factor X and is taken orally especially to prevent and treat deep vein thrombosis and pulmonary embolism and to reduce the risk of stroke related to atrial fibrillation
Note:
Rivaroxaban is marketed under the trademark Xarelto.